아리바이오 Rights issue filings (유상증자)

Fields as filed (DART)

Values are exactly as filed. We did not round or edit them. A hyphen in the original means no value.

New shares, common (shares)

-

New shares, other classes (shares)

425,000

Par value per share (KRW)

500

Total shares before issue, common

28,429,512

Total shares before issue, other classes

-

Use of funds, facilities (KRW)

-

Use of funds, business acquisition (KRW)

-

Use of funds, operations (KRW)

2,295,000,000

Use of funds, debt repayment (KRW)

-

Use of funds, buying other companies' securities (KRW)

-

Use of funds, other (KRW)

9,180,000,000

Issue method

제3자배정증자

Other filings by the same company

• 아리바이오Other 2026-09-29

  [기재정정]주요사항보고서(회사합병결정)

• 아리바이오Other 2026-09-22

  [기재정정]주요사항보고서(회사합병결정)

• 아리바이오Other 2026-09-18

  [기재정정]주요사항보고서(유상증자결정)

• 아리바이오Other 2026-08-27

  [기재정정]주요사항보고서(유상증자결정)

A corrected report gets its own filing number. If numbers differ, the later filing is the newer one.